Market Snapshot

BSE Sensex: 75415.35 0.31%
BSE 500: 35413.94 0.21%
BSE 200: 11047.96 0.30%
BSE 100: 25157.55 0.32%
BSE BANKEX: 60904.45 1.18%
BSE IT: 28065.42 -0.32%
Nifty 50: 23719.3 0.27%
Nifty 500: 22651.3 0.21%
Nifty 200: 13675.9 0.27%
Nifty 100: 24669.3 0.30%
Nifty Midcap 100: 61389.3 0.14%
Nifty Small 100: 17956.2 -0.15%
Nifty IT: 28912.45 -0.37%
Nifty PSU Bank: 8006.15 0.22%

News:

Sterlite Technologies? arm win...
NTPC Q4 PAT jumps 34% YoY to R...
Divis Lab Q4 PAT climbs 13% Yo...
NTPC Green Energy Q4 PAT slide...
RailTel Corp bags Rs 31-cr IT ...

Syncom Formulations (India) Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

22 May 2026 | 03:59 PM

14.33

0.06 (0.42%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-27.26%

Return (1Y)

Underperformed BSE Healthcare by 38.43%
More Volatile

2.26%

Standard Deviation (1Y)

Higher than BSE Healthcare by 1.42%
Inconsistent Performer

1/12

Months

underperformed BSE Healthcare
AxisDirect View

No View

52 Week High-Low

23

10

News & Announcements

Syncom Formulations (India) consolidated net profit rises 42.28% in the March 2026 quarter

15 hours ago

Syncom Formulations (India) standalone net profit rises 40.40% in the March 2026 quarter

15 hours ago

Syncom Formulations (India) schedules board meeting
9 days ago

Syncom Formulations (India) schedules board meeting

14 - May - 2026 12:00 | 9 days ago

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 22 May 2026.
Syncom Formulations (India) consolidated net profit rises 45.46% in the December 2025 quarter
100 days ago

Syncom Formulations (India) consolidated net profit rises 45.46% in the December 2025 quarter

12 - Feb - 2026 12:00 | 100 days ago

Net profit of Syncom Formulations (India) rose 45.46% to Rs 18.91 crore in the quarter ended December 2025 as against Rs 13.00 crore during the previous quarter ended December 2024. Sales declined 9.72% to Rs 115.14 crore in the quarter ended December 2025 as against Rs 127.53 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 115.14 127.53 -10

OPM % 18.42 11.55 -

PBDT 26.45 18.57 42

PBT 25.09 17.26 45

NP 18.91 13.00 45

Powered by Capital Market - Live News

Price vs Volume

1D
5D
1M
3M
1Y
3Y
5Y
MAX

Stock Trivia

FII shareholding in Syncom Formulations (India) Ltd has decreased by -18.16% since past 3 Months
MF shareholding in Syncom Formulations (India) Ltd has increased by 5% since past 3 Months
FII shareholding in Syncom Formulations (India) Ltd has increased by 97.78% since past 1 Year
MF shareholding in Syncom Formulations (India) Ltd has increased by 16.67% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

×

Online trading for clients based in USA and Canada is restricted. You can continue placing orders through mapped dealers offline

OK

vV5.0.0.6-60